Biogen and Ginkgo to collaborate for development of Novel Gene Therapy Manufacturing Platform
Collaboration aims to develop a next-generation AAV production platform to help accelerate Biogen’s efforts to bring ...
Read moreCollaboration aims to develop a next-generation AAV production platform to help accelerate Biogen’s efforts to bring ...
Read moreBiogen Inc. today announced that its next generation manufacturing facility in Solothurn, Switzerland has received a ...
Read moreCollaboration aims to identify novel AAV capsids with enhanced properties to facilitate the development of new ...
Read moreBiogen Inc. and Bio-Thera Solutions, Ltd. today announced that they entered into a commercialization and license ...
Read moreTYSABRI is a well-established high-efficacy treatment that now provides two routes of administration enabling flexibility to ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.